Friday, July 10, 2026

pharma · Extensive-stage Small Cell Lung Cancer · Gastric Cancer

Shanghai Medical College

Shanghai Medical College trial registry — 4 ClinicalTrials.gov studies with program phase, status, and indication context.

CN HQ
20 Employees
NMPA registrant Type
Company details
Status
Public
HQ
CN
Employees
20
Programs
4
Drugs
3
Patents
0
Intelligence · Clinical Trials

Shanghai Medical College clinical trials

Registry index of 4 ClinicalTrials.gov studies linked to Shanghai Medical College programs — each row shows trial ID, program name, phase, status, and indication.

Shanghai Medical College trial registry — 4 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

4 updates

Latest clinical program signals indexed for Shanghai Medical College.

  1. tissue-of-origin (ORIGIN-PanCA○R) profiling — Phase 3

    Clinical update
  2. EOF5 — Phase 2

    Clinical update
  3. IGEV — Phase 2

    Clinical update
  4. anlotinib — Phase 2

    Clinical update

Trial registry

4 studies